JENNIFER BICKFORD: Open Payments
NPI 1992133060 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 61 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $1,560 · 2025 $1,287
Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $214 |
| Regeneron Healthcare Solutions, Inc. | 7 | $168 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Olympus America Inc. | 1 | $113 |
| GENZYME CORPORATION | 5 | $108 |
| Calliditas Therapeutics US Inc. | 4 | $79 |
| Apellis Pharmaceuticals, Inc. | 3 | $56 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| Insmed, Inc. | 3 | $46 |
| Verona Pharma, Inc. | 2 | $38 |
Products named: DUPIXENT, UPTRAVI, NUCALA, Single-Use flexible Video Bronchoscope, TRELEGY ELLIPTA, TARPEYO, INSPIRE, Arikayce.
Industry payments across NV — which companies pay providers there.
